These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2356365)

  • 1. Recombinant human erythropoietin: implications for nephrology. Proceedings of a symposium. Quebec City, Canada.
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):1-72. PubMed ID: 2356365
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythropoietin, a milestone in the history of nephrology].
    Uehlinger DE; Frey FJ
    Ther Umsch; 1995 Oct; 52(10):672-7. PubMed ID: 7482378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of human recombinant erythropoietin in patients for chronic renal insufficiency].
    Wanic-Kossowska M
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):129-31. PubMed ID: 8090663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recombinant human erythropoietin].
    Frenken LA; Koene RA
    Ned Tijdschr Geneeskd; 1988 Mar; 132(10):432-4. PubMed ID: 3347279
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing anemia. What do we do now? Views from Canada.
    Mendelssohn DC; Muirhead N; Manns BJ
    Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988
    [No Abstract]   [Full Text] [Related]  

  • 9. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells.
    Ganser A; Bergmann M; Völkers B; Grützmacher P; Scigalla P; Hoelzer D
    Exp Hematol; 1989 Jun; 17(5):433-5. PubMed ID: 2714423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to recombinant human erythropoietin therapy in a child with renal failure due to primary hyperoxaluria type 1.
    Lavoratti GC; Seracini D; Pela I; Materassi M; Vichi GF; Di Lollo S; Bartolozzi G
    Nephrol Dial Transplant; 1994; 9(11):1645-8. PubMed ID: 7870357
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant human erythropoietin therapy: an overall approach to the anemia of chronic renal failure. Proceedings of symposia. December 11-13, 1988, San Antonio, Texas.
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):1-25. PubMed ID: 2757024
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro and in vivo effects of recombinant human erythropoietin on human hemopoietic progenitor cells.
    Ganser A; Bergmann M; Völkers B; Grützmacher P; Hoelzer D
    Contrib Nephrol; 1988; 66():123-30. PubMed ID: 3292145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of renal anemia using synthetic human erythropoietin].
    Blumberg A; Zehnder C
    Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of anemia in patients with chronic renal insufficiency with recombinant human erythropoietin].
    Djukanović Lj; Lezaić V
    Srp Arh Celok Lek; 1996; 124(3-4):93-7. PubMed ID: 9102827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin: from gene to therapeutic agent].
    Bauer C
    Schweiz Rundsch Med Prax; 1994 Jun; 83(23):698-701. PubMed ID: 8016510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacokinetics of recombinant human erythropoietin].
    Siniukhin VN; Stetsiuk EA; Lovchinskiĭ EV; Lebedev SV; Iarmolinskiĭ IS; Liakhov VV
    Ter Arkh; 1994; 66(8):60-2. PubMed ID: 7985158
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant erythropoietin: 10 years of clinical experience.
    Valderrábano F
    Nephrol Dial Transplant; 1997; 12 Suppl 1():2-9. PubMed ID: 9075222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.